Report #2829070

Received Mar 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: MA
Recovered: Unknown
Vaccinated: Feb 10, 2025
Onset: Feb 10, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	945660	IM

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

16 Year Old Received Dose 1 of HEPLISAV-B; Initial report received on 11-Feb-2025. A nurse reported that a 16-year-old female received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history was reported. No concomitant medications were reported. On 10-Feb-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot # 945660, expiration date 31-Jan-2027, NDC# 43528-0003-05)] intramuscularly in the arm. The patient was 16 years old at the time she received HEPLISAV-B. The patient had no adverse effects. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.